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Abstract Salt and fluid absorption and secretion are two
processes that are fundamental to epithelial function and
whole body fluid homeostasis, and as such are tightly
regulated in epithelial tissues. The CFTR anion channel
plays a major role in regulating both secretion and
absorption in a diverse range of epithelial tissues, including
the airways, the GI and reproductive tracts, sweat and
salivary glands. It is not surprising then that defects in
CFTR function are linked to disease, including life-
threatening secretory diarrhoeas, such as cholera, as well as
the inherited disease, cystic fibrosis (CF), one of the most
common life-limiting genetic diseases in Caucasian popu-
lations. More recently, CFTR dysfunction has also been
implicated in the pathogenesis of acute pancreatitis,
chronic obstructive pulmonary disease (COPD), and the
hyper-responsiveness in asthma, underscoring its funda-
mental role in whole body health and disease. CFTR
regulates many mechanisms in epithelial physiology, such
as maintaining epithelial surface hydration and regulating
luminal pH. Indeed, recent studies have identified luminal
pH as an important arbiter of epithelial barrier function and
innate defence, particularly in the airways and GI tract. In
this chapter, we will illustrate the different operational
roles of CFTR in epithelial function by describing its
characteristics in three different tissues: the airways, the
pancreas, and the sweat gland.
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Introduction
The basic toolkit for epithelial electrolyte and fluid
absorption and secretion
Epithelial tissues are composed of one or more layers of
closely assembled cells that cover a surface or that line a
cavity. The main characteristic of epithelial cells is that
they are polarised; the plasma membrane in contact with
the external environment is called the mucosal or apical
membrane, whereas the basolateral (serosal) membrane
faces toward the interstitium. Both membranes have dis-
tinct roles due to their localization and differential
expression of proteins (Fig. 1a). The basolateral membrane
uptakes nutrients, ions and oxygen from the blood, and
disposes of the cellular waste products. Because the apical
membrane is in contact with the external environment, it
serves both as a physical and chemical barrier to prevent
potential pathogens or toxic matter reaching the blood-
stream. The epithelial cells are joined together by points of
contacts separating the apical and basolateral membrane:
the interstitium is separated from the apical external milieu
by junctional proteins. These proteins were originally
described by histologists and grouped into four different
structures: the zona occludens (tight junctions), zona
adherens, macula adherens, and gap junctions. These are
fundamental to maintain the polarity of the epithelia and,
therefore, for the directional movement of ions and fluid
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that underscore the processes of absorption and secretion
[1]. Gap junctions also allow electrical communication
between cells as well as the diffusion of low molecular
weight solutes.
The overall mechanism for electrolyte and fluid trans-
port depends on the tissue and mainly on the differential
expression, and distribution, of ion channels, exchangers,
cotransporters, and pumps. Salt and fluid move either
through the paracellular (between the cells) or transcellular
(through the cells) pathways (Fig. 1a). The transcellular
route of electrolyte transport requires active (ATP-depen-
dent) or passive (following electrochemical gradients)
transport of ions. The paracellular route is a passive process
that is ultimately controlled by the prevailing transepithe-
lial electrochemical gradients, as well as the cation-to-
anion selectivity of the tight junctions. Indeed, the differ-
ential expression of claudins, which have been extensively
studied in kidney epithelia [2–4], have been shown to
regulate paracellular permeability, through their ability to
modulate the charge, water, and size selectivity of the tight
junctions [5]. Furthermore, recent patch clamp studies from
polarised cultures of kidney epithelial cells have shown
that claudin-4 appears to act as a chloride-selective pore,
with properties very similar to conventional membrane
spanning ion channels [6] Transepithelial electrical resis-
tance (TEER) measurement is used to assess the barrier
function of epithelial tissues, or cells grown on semi-per-
meable supports, and reflects the paracellular as well as
transcellular conductivity. It is known that specific tight
junction proteins largely influence epithelial resistance [7],
and in the early 1970s, Fro¨mter and Diamond used this
measurement to classify epithelia into leaky (with a low
TEER) and tight (TEER[ 500 X cm-2). Leaky epithelia
also generate a small transepithelial voltage (Vt) that is due
to a low junctional resistance as well as to electroneutral
transport (i.e., cotransport of a cation with an anion or
exchange of an anion for another anion). In contrast, tight
epithelia can produce high Vt, and are able to maintain
large ion concentration and osmotic gradients [8]. There-
fore, leaky epithelia are mainly involved in isotonic
electrolyte and fluid transport, whereas tight epithelia are
mainly involved in hypo- or hypertonic salt and fluid
absorption or secretion.
Generally, salt absorption depends on the active
transepithelial absorption of sodium (Na?) ions, which
creates an electrochemical driving force for passive chloride
(Cl-) transport in the luminal to basolateral direction
(Fig. 1b). This, in term, creates a salt concentration gradient
Fig. 1 Basic characteristics of an epithelial layer. a Epithelial cells
are joined together by junctions [tight junctions (TJ), gap junctions
(GJ)]. Uptake of nutrients and oxygen, and removal of cellular waste
products occur on the basolateral surface. Water and ion transport can
occur through the transcellular or paracellular pathways. b Absorption
is mainly driven by active Na? absorption through ENaC in the apical
membrane and the Na?/K?-ATPase in the basolateral membrane
creating an electrochemical driving force for paracellular passive Cl-
transport. Water then follows either through aquaporins or the
paracellular pathway. c Secretion is mainly driven by Cl- secretion
through CFTR and other Cl- channels in the apical membrane.
NKCC1 and the coupled action of an anion exchanger and NBC in the
basolateral membrane accumulate Cl- in the cell. Active Cl-
secretion creates the driving force for Na? movement across the
epithelium through the paracellular pathway and water transport
occurs paracellularly and/or transcellularly. Red and green arrows
show active transport, and yellow arrows show passive transport
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across the epithelium provoking water to be absorbed pas-
sively by osmosis. Na? absorption is generally governed by
the activity of the apically located epithelial Na? channel
(ENaC), a heterotrimer composed of alpha, beta, and gamma
subunits. Na? efflux across the basolateral membrane is then
driven by the Na?/K?-ATPase, which ultimately maintains
an inwardly directed Na? gradient necessary for absorption.
In addition, both apical and basolateral K? channels are
essential to maintain a suitable negative membrane potential
for Na? influx to occur (Fig. 1b).
In contrast, transcellular salt secretion is mainly con-
trolled by Cl- exit across the apical membrane and this
occurs predominantly via CFTR, although a number of
distinct Cl- channels, such as calcium-activated Cl-
channels (CaCC), and solute carrier (SLC)26A9, are also
involved, depending on tissue. Secretion depends on active
Cl- transport, which creates the driving force for Na?
movement across the epithelium through the paracellular
pathway (Fig. 1c). The increased salt concentration on the
luminal surface generates an osmotic driving force for
water to be secreted, producing an isotonic secretion. For
both processes, water moves either passively through the
paracellular pathway or transcellularly via aquaporins, or
by both routes [9–11] (Fig. 1b, c). It is important to note
that in addition to Cl-, CFTR and ANO1 also conduct
HCO3
- and that transport of this anion will also contribute
to transepithelial fluid secretion (not shown on Fig. 1).
Under normal physiological electrochemical gradients, and
because CFTR is about 5 times more conductive for Cl-
than HCO3
-, transport of Cl- by CFTR accounts for the
majority of fluid secretion in most secretory tissues.
However, the secretion of HCO3
- does play a key role in
modulating the pH of the secreted fluid, which is discussed
in more detail below.
In CFTR expressing tissues, fluid secretion is primarily
controlled by the extent of transcellular Cl- transport, with
the rate of Cl- exit across the apical membrane being the
rate-limiting step. Chloride secretion is essentially a two-
stage process, which begins with the active accumulation
of Cl- across the basolateral membrane, through the Na?
K? 2Cl- cotransporter (NKCC1), a secondary-active
transporter that uses the inwardly directed Na? gradient,
established by the Na?/K?-ATPase, to accumulate Cl-
above electrochemical equilibrium. In addition, recent
evidence suggests that a basolateral Cl-/HCO3
- anion
exchanger (most likely SLC4A2) working in parallel with
an Na?-bicarbonate cotransporter (NBC) can also accu-
mulate Cl- within some epithelial cells [12]. In many
epithelial tissues, Cl- exit across the luminal membrane
occurs via CFTR. The total CFTR Cl- conductance of the
apical membrane is dependent on three parameters: the
activity, or open state probability (Po) of CFTR, which is
controlled predominantly via cAMP/PKA phosphorylation
as described in chapter ‘‘Biochemistry and physiology of
CFTR’’; the number or density of CFTR channels (N), and
finally the single channel conductance (Gs), which itself is
governed by the electrochemical gradient across the apical
membrane (membrane potential and Cl- concentration).
The net transport of Cl- across the epithelium then drives
passive Na? transport via a cation-selective paracellular
route, and water follows osmotically. Importantly, as Cl-
exits the cells the apical membrane will depolarise which
will ultimately limit Cl- secretion, as the apical membrane
potential moves towards the Cl- equilibrium potential. In
some epithelial cells, intracellular Cl- also falls due to
CFTR activity, which can lead to activation of several
protein kinases that alter CFTR anion permeability (see
section on pancreas).
The role of CFTR in epithelia has been extensively
studied in relation to the affected organs in cystic fibrosis
(CF). As stated in Chapter ‘‘Cystic Fibrosis: a clinical
view’’, CF is the most common genetically inherited dis-
ease in Caucasian populations (1 in 3500 newborns in
Europe) [13, 14] and 70–90 % of CF individuals harbour
the F508del mutation on at least one allele [15], which
results in misfolding and incorrect processing of CFTR to
the apical membrane. One of the first symptoms associated
with CF, and occurring in around 17 % of CF patients, is
meconium ileus; an obstruction of the bowel due to thick
meconium and 98 % of babies with meconium ileus has
CF. Distal intestinal obstruction syndrome also has a life-
time prevalence of 8 % in children with CF and 16 % in
adult CF patients, and constipation occurs in around 50 %
of CF patients [16] (median of 16 % in the general popu-
lation [17]). Moreover, historically, some of the first
suspected descriptions of CF come from the XVI century
and associated a salty skin and pancreatic damage with
early childhood death [18]. Finally, the main cause of
mortality and morbidity in CF is the lung pathology in
which thick and sticky mucus blocks the airways promot-
ing the development and persistence of virulent pathogens.
To develop further the fundamental, but contrasting, roles
of CFTR in the physiology of epithelia, we will describe its
role in three different CF-affected organs; the lungs, the
pancreas, and the sweat gland. However, it is important to
note that CFTR plays a fundamental role in electrolyte
transport throughout most of the intestinal tract, as well as
in the female and male reproductive tracts, but due to space
limitations, these topics will not be discussed further. For
the interested reader, several recent reviews describe in
detail the role of CFTR in anion (Cl- and HCO3
-) and
fluid transport in these tissues, together with diseases
associated with defective CFTR, such as CF secretory
diarrhoeas and infertility [19–24].
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Role of CFTR in the lungs
The main function of the lung is to provide oxygen to the
bloodstream and, therefore, to all organs in the body, and to
remove carbon dioxide from the bloodstream out to the
atmosphere. The lung is composed of the conducting air-
ways and the respiratory airways (Fig. 2). Both entities
serve a particular function. The conducting airways com-
posed of the nose, mouth, pharynx, larynx, trachea, bronchi
and conducting bronchioles, conduct and warm up the air
from the upper airways to the respiratory airways (respi-
ratory bronchioles, alveolar ducts, alveoli) where gas
exchange occurs. The epithelia lining the surfaces of the
conducting and the respiratory airways have different cell
composition: the bronchial epithelium is mainly composed
of ciliated cells, goblet cells and basal cells (Fig. 2a),
whereas the alveolar epithelium consists of alveolar type I
and alveolar type II cells (Fig. 2b). It is also important to
note that submucosal glands are found in the cartilaginous
conducting airways and are composed of distinct regions
with different types of cells, including ciliated and non-
ciliated serous and mucous cells [25], with different
functions (not shown in the figure but described below).
The conducting airways also have a role of preventing
any noxious matter from reaching the alveolar gas
exchange site. To accomplish this role, the epithelial cells
lining the airways are protected from the inspired air by a
thin (*10 lm) liquid layer called the airway surface liquid
(ASL) that is composed of a lower periciliary layer
(*7 lm), in which cilia beat to remove the inhaled
particles and pathogens trapped in the upper mucus layer
(Fig. 2a). To maintain an efficient mucociliary clearance,
the process that allows the removal of trapped particulate
matter by the coordination of fluid secretion and ciliary
beating, ASL hydration is tightly regulated by the transport
of ions and water across the surface epithelia as well as by
fluid secretion arising from submucosal glands. Indeed,
Ballard et al. provided evidence that the ASL is mainly
secreted by the glands lying below the mucosal layer. They
showed in pig airways that the rate of fluid secretion
induced by acetylcholine was unaffected by the removal of
the surface epithelium [26]. In submucosal glands, mucous
cells are mainly localised in the tubules distal from the
collecting duct, whereas the CFTR-expressing serous cells
are predominantly present in the distal ducts and acini.
Mucous cells secrete gel-forming mucins (mainly MUC5B)
as well as fluid, but the serous cells are the primary origin
of the fluid component of the gland secretions, secreting
solutes, fluid and innate defence molecules [27]. Although,
in the upper airways, much of the ASL originates from the
submucosal glands, surface epithelia have a critical role in
regulating final ASL volume and composition. This is
because surface airway epithelial cells express both ENaC
and CFTR and, therefore, are able to absorb Na? as well as
secrete Cl-. Studies using thin film cultured human bron-
chial epithelial cells (HBEs) have shown that both Na?
absorption and Cl- secretion regulate ASL height and
composition [28, 29]. In CF airways, the ASL is depleted
which strongly affects mucociliary clearance and, there-
fore, the eradication of bacterial infections. Moreover, it
Fig. 2 Cellular components of the airways. The airways are
composed of the conducting airways (a) and the respiratory airways
(b). a The conducting airways are covered by an aqueous film called
the airway surface liquid (ASL) which is composed of the periciliary
layer (PCL) and the mucus layer (M). Three types of cells constitute
the conducting airways: the ciliated cells (CC), goblet cells (GC), and
basal cells (BC). b The respiratory airways are composed of the
alveolar type I (ATI) and type II (ATII) cells and are covered by the
alveolar lining fluid (ALF) that prevent alveoli from collapsing
V. Saint-Criq, M. A. Gray
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was shown by Joo et al. that cAMP agonists failed to
induce secretion by submucosal glands from CF patients
[30]. As stated above, because of the importance of the
submucosal glands in the formation of the ASL, it is likely
that any defect in CFTR in these glands will strongly affect
ASL homeostasis. Although CFTR is apparently not
expressed in mucous cells [31], the defect in fluid secretion
from serous cells affects mucin secretion (by mucous cells)
as well as its hydration [32] and leads to severe mucus
plugging within the glands, probably because of an acidic
environment within the glands (see below).
In surface epithelia, ASL depletion was thought to be
due mainly to a lack of Cl- secretion that leads to a lack of
an osmotic gradient, which, in turn, prevents fluid secre-
tion, but it may also involve enhanced absorption through
ENaC. Indeed, it has been shown that CFTR regulates
other ion channels and transporters, and critically is
involved in ASL pH regulation and innate immunity
through regulation of secretion of antioxidant and antimi-
crobial molecules. All these functions of CFTR act together
to maintain a close to sterile environment in the lungs that
prevents pathogens and noxious agents from entering the
blood circulation. Indeed, proper hydration of the ASL is
crucial for an efficient mucociliary clearance, and recent
studies have shown that ASL pH homeostasis is essential
for bacterial killing [33, 34], mucus rheology [35] and fluid
homeostasis [36].
Regulation of airway surface fluid composition
and hydration
Surface airway epithelial cells, as well as serous cells of the
submucosal glands, secrete Cl- and HCO3
- in response to
agents increasing intracellular cAMP (VIP, adenosine and
noradrenaline) and/or Ca2? (acetylcholine, histamine or
ATP) and this controls ASL volume and composition. As
described in the introduction, for many epithelial cells, the
Na?/K?-ATPase actively transports Na? out of the cells
producing a transmembrane electrochemical gradient
allowing for the cotransport of Na?, K?, and Cl- through
NKCC1 at the basolateral membrane, thereby increasing
intracellular Cl- concentration above equilibrium. In ser-
ous cells, it has been shown that Cl- can also be
accumulated at the basolateral membrane by two other
mechanisms: (1) through the coupled action of a Na?/H?
exchanger (NHE) and a Cl-/HCO3
- exchanger and (2)
parallel operation of a Cl-/HCO3
- exchanger with NBC
[12, 37]. At the apical membrane, Cl- is secreted through
CFTR, CaCCs or SLC transporters and channels.
In CF, an enhanced Na? absorption has also been
reported and one hypothesis to explain this finding is that
CFTR normally downregulates ENaC activity in non-CF
cells. This was first suggested from studies in which
measurements of nasal potentials in CF patients showed a
large response to amiloride (a highly selective ENaC
inhibitor) that was not seen in non-CF patients [38, 39].
Later work from a b-ENaC overexpressing mouse [40]
provided further support, since these transgenic mice
exhibited a lung phenotype characteristic of human CF
airways. Indeed, airway epithelia isolated from this model
showed CF ASL depletion, dehydrated mucus, neutrophilic
inflammation, and poor bacterial clearance. However, the
regulation of ENaC by CFTR is an ongoing debate as some
studies do not report the same results [41]. In an attempt to
reverse the b-ENaC mouse phenotype, Grubb et al. [42]
developed another mouse strain overexpressing human
CFTR that were bred with the b-ENaC mice. The
hypothesis was that increasing the amount of CFTR would
restore a ‘‘normal’’ CFTR/ENaC ratio and reverse the CF-
like phenotype of b-ENaC mice airways. In this study, the
double transgenic mice (hCFTR/b-ENaC) showed the same
phenotype as b-ENaC mice, characterised by a reduced
survival rate, airways obstruction and depleted ASL
showing that in this model, CFTR was not able to rescue
the lung phenotype observed in the b-ENaC mice [42].
There are a large number of studies supporting the regu-
latory effect of CFTR on ENaC in human airways (Fig. 3),
but the mechanisms involved are still unclear due to con-
tradictory results in different studies. A 2011 patch-clamp
study from Lazrak et al. reported that CFTR regulates
ENaC activity in isolated type II alveolar cells, even when
CFTR protein levels were minimal [43]. On the other hand,
the recent generation of CF pigs (both CFTR-/- and
F508del) do not show any increased Na? or water
absorption compared to wild-type animals, in spite of an
increased amiloride-sensitive voltage, and short-circuit
current, observed in airway epithelial cultures from these
animals [44]. Although the direct or indirect regulatory
effect of CFTR on ENaC still needs to be confirmed,
several groups are pursuing ENaC inhibitors as a thera-
peutic approach to increase ASL depth, and the available
data show that interfering with ENaC activity could
potentially be beneficial in CF to rehydrate the ASL [45].
To maintain an optimally hydrated ASL, CFTR also
regulates other Cl- channels and transporters, some of
which belong to the SLC26 family [46]. The mammalian
SLC26 family of anion exchangers and channels is com-
posed of 10 genes that encode proteins with a C- and
N-termini that frame a transmembrane domain. In the
C-terminus, there is a regulatory region called the STAS
(sulphate transporter and anti-sigma factor antagonist)
domain. Mutations in human SLC26 genes lead to tissue
specific diseases such as autosomal recessive non-syn-
dromic deafness, DFNB4, and Pendred Syndrome in the
SLC26A4 gene [47], and studies in mice models have shed
light on the organ distribution of other SLC26 transporters.
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Among the 10 identified members of the SLC26 family,
two have been shown to be expressed in airway cells,
SLC26A4 and SLC26A9. Importantly, genome-wide
association studies have recently demonstrated a significant
association between single nucleotide polymorphisms
(SNPs) in SLC genes and CF disease severity. Correlations
were found with susceptibility to meconium ileus, Pseu-
domonas infections and decline in pulmonary function in
CF children (SLC9A3; Na?/H? exchanger) and CF-related
diabetes (SLC26A9; Cl-/HCO3
- transporter) [48, 49].
Among the latest discovered SLC26 are the SLC26A7, A8,
and A9 [50]. SLC26A9 is predominantly expressed in the
brain and lungs, and recent work suggests that it plays an
important role in airways hydration and mucus homeostasis
as a polymorphism in the 3’UTR region has been shown to
be associated with asthma [51]. To study the function of
this transporter, Lohi et al. injected Xenopus laevis oocytes
with SLC26A9 cRNA and measured the uptake of radio-
labelled sulphate, Cl- and oxalate. They reported the
transport of all three anions by SLC26A9 and an inhibition
of sulphate transport by DIDS and thiosulphate, implying
that the protein acted as an anion exchanger, similar to
several other SLC26 members (A3, A4 and A6). Further
characterisation of this transporter reported a small effect
of the specific CFTR inhibitor, CFTR-Inh172, in patch-
clamp experiments from oocytes [52] but a more signifi-
cant effect of GlyH-101 (another CFTR inhibitor, but with
lower selectivity) in SLC26A9-transfected HEK 293 [53].
However, it was shown in 2009 that SLC26A9 was regu-
lated by CFTR in HBEs and that the forskolin response was
enhanced in cells coexpressing CFTR and SLC26A9, when
compared to HEK-293 expressing CFTR alone. Since the
increase in current was much greater than the addition of
each response alone, this suggested that both channels
interacted synergistically in response to forskolin. More-
over, combined data from patch-clamp experiments in
HEK 293 cells and short-circuit current experiments in
HBE cells showed that the constitutive basal Cl- current
observed in HBE cells was likely to be due to SLC26A9.
This current was absent from HBE cells cultured at air
liquid interface (ALI) from CF patients, and furthermore,
these cells lacked the signature currents, typical of
SLC26A9 alone or coexpressed with WT-CFTR in HEK
293 coexpressing F508del-CFTR and SLC26A9 [53],
suggesting that the mutant CFTR prevented SLC26A9
activity. However, in the same year, Chang et al. showed
that this anion transporter was inhibited by the regulatory
domain of CFTR and that this effect occurred through an
interaction with the STAS domain of SLC26A9 [54].
Clearly, the effect of CFTR on SLC26A9 activity requires
further investigation, but in the airways at least, it seems
both channels work together to maintain ASL hydration
(Fig. 3).
CFTR has also been shown to regulate Ca2? activated
Cl- secretion, potentially via changes in CaCCs (Fig. 3).
The histamine or UTP peak secretory response was
enhanced in cultured CF airway epithelial cells and
freshly excised nasal tissues from CF patients, respec-
tively [55, 56]. In CF mice, enhanced Ca2?-dependent
Cl- secretion was also detected [57]. In a study from
2011, soon after the identification of the CaCC as being
encoded by TMEM16A (also called Anoctamin 1, ANO1)
[58–60], Ousingsawat et al. reported that the activation of
CFTR inhibited ANO1 in a bronchial epithelial cell line
[61] and also showed a molecular interaction between the
two channels in an overexpressing model using HEK293
cells. These are a few examples of how CFTR regulates
other channels to maintain a fully hydrated ASL. How-
ever, CFTR is also involved in regulating the movement
of water across the epithelium through the transcellular
pathway by regulating aquaporins such as aquaporin 3 in
non-CF cells [62]. Studies performed in CF and non-CF
cell lines, by two different groups, also showed that
CFTR modulates the paracellular pathway. When CFTR
was activated in non-CF cells, the transepithelial electrical
resistance decreased and paracellular conductance
Fig. 3 Ion transport in the airways. On the apical surface, CFTR
drives Cl- and HCO3
- secretion and regulates Na? absorption by
inhibiting ENaC. CFTR also positively regulates the Cl- channels
ANO1 and SLC26A9 as well as the anion exchanger SLC26A4,
increasing Cl- and HCO3
- secretion and therefore increasing ASL
hydration and pH. Na? and water follow the electrochemical gradient
through the paracellular pathway. On the basolateral membrane,
NKCC1 accumulates Cl- intracellularly supported by the Na?/K?-
ATPase. K? recycling across the basolateral membrane occurs for
proper function of the Na?/K?-pump
V. Saint-Criq, M. A. Gray
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increased. CFTR inhibition led to a disorganisation of
F-actin and a-tubulin that was also observed in CF
epithelia [63] and involved a myosin II dependent
mechanism [64].
Another hallmark of CF airway disease that is also
found in COPD is the accumulation of mucus that forms
mucus plugs on the surface of airway epithelial cells. The
composition of mucus includes water, ions, and macro-
molecules with protective functions such as anti-
microbial, anti-protease, and anti-oxidant activity. Mucins
are glycoproteins that are responsible for the viscoelastic
property of mucus, which is crucial for an effective
mucociliary clearance. Because organs affected in CF are
mainly mucus producing epithelia, it has been proposed
that a defect in CFTR expression and/or activity would
affect mucus production and properties [65]. However,
the fact that some mucus producing organs do not show
complete obstruction in CF, such as the salivary and
lacrimal glands, suggest an indirect role for CFTR in the
regulation of mucus production. Moreover, the phenotype
of the overexpressing b-ENaC mice (described earlier in
this chapter) suggested that CFTR affects mucus by
activating and/or inhibiting other factors, such as pH and
HCO3
-.
In the lower airways, alveolar cells must remove water
from their surface to permit gas exchange. This is a major
function after birth when the lungs are filled with amniotic
fluid, but it is also involved in the clearance of fluid in the
resolution of pulmonary oedema in adulthood. Cardiogenic
lung oedema is due to an elevated hydrostatic pressure
secondary to a high pulmonary venous pressure. It was
thought that fluid movement into the alveolar lumen was
due to a passive movement of water through the paracel-
lular pathway due to the elevated pressure. However, a
recent study has shown that active signalling could be
involved in this process and that CFTR could mediate
alveolar Cl- and fluid secretion [66]. However, other
studies have shown that this anion channel is also involved
in fluid resorption in alveolar cells. Na? absorption plays a
crucial role in this mechanism [67–70], but recent evidence
points towards a control of fluid absorption by CFTR.
Using in situ perfused lungs from wild-type mice, Fang
et al. showed that inhibition of Cl- channels, as well as
Cl- substitution by gluconate, inhibited fluid clearance by
50 % [71]. Increasing intracellular cAMP led to an
increase in fluid clearance, and this could be inhibited by
addition of glibenclamide, an inhibitor of CFTR, con-
firming the role of CFTR in alveolar fluid resorption. The
same group validated their findings in primary human
alveolar type II cells cultured at air–liquid interface. Inhi-
bition of CFTR with CFTR-Inh172 did not have any effect
on basal fluid absorption but inhibited *35 % of cAMP-
induced fluid absorption [72]. A more recent study by
Korbmacher et al., in which they used a novel Deuterium
oxide (D2O) dilution method in conjunction with short-
circuit measurements in Ussing chamber experiments,
showed that inhibition of ENaC abolished more than 70 %
of water resorption. Inhibition of CFTR (using CFTR-
Inh172 or glibenclamide) reduced basal water resorption
by *15–20 %, whereas a more general inhibition of Cl-
channels by NPPB blocked almost 60 % of this process,
demonstrating the involvement of CFTR and other apical
Cl- channels in water resorption across the alveolar
epithelium [73].
Regulation of the ASL pH by CFTR
Many recent studies have highlighted the importance of
ASL pH regulation in airways homeostasis. Indeed, it was
first demonstrated in the 1970s that the pancreatic secre-
tions in patients with CF were acidic (see section on
pancreas), and some years later, it was hypothesized that
the defect in HCO3
- secretion caused by defective CFTR
could also occur in the lungs, and therefore decrease the
ASL pH [74]. An acidic ASL pH has also been demon-
strated in other lung pathologies such as asthma [75],
COPD [76] and acute respiratory distress syndrome [77].
Although the link between CFTR and asthma is still con-
troversial [78–81], it is now well established that COPD
shares some common features with CF, including
bronchiectasis, mucus plugging, and inflammation. The
primary cause of COPD is a chronic exposure to oxidative
insults such as cigarette smoking or passive exposure to
cigarette smoke. Cigarette smoke exposure leads to an
increase in inflammation and a decrease in CFTR activity.
It was first reported in the early 1980s, before the identi-
fication of the CFTR gene, that cigarette smoke decreased
Cl- secretion which could not be prevented by adminis-
tration of antioxidants [82]. In 2006, Cantin et al. showed
that this effect was due to an inhibition of CFTR [83], and
it was later demonstrated that cigarette smoke actually
induced CFTR internalisation, and this led to ASL dehy-
dration [84], potentially contributing to the development of
COPD pathology.
There is now more evidence to show that the lack of
HCO3
- secretion in CF airways leads to a reduced ASL
pH, and this further deteriorates the lung pathophysiology.
An acidic ASL pH was demonstrated in the early 2000s in
primary HBE cell cultures from CF and non-CF patients
[85]. This study also showed that activating CFTR by
increasing intracellular cAMP, increased ASL pH in non-
CF epithelia but had the opposite effect in CF monolayers.
Because normal submucosal glands are capable of secret-
ing HCO3
- and CFTR conducts this anion, it has be
hypothesized that submucosal gland fluid, and therefore
ASL pH, would be affected in CF. Indeed, Song et al.
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showed that freshly collected fluid secreted by submucosal
glands from CF patients was more acidic that glands from
non-CF individuals [86]. Also in a 2012 study on newborn
CF pigs, Pezzulo et al. showed that the ASL was more
acidic when compared to wild-type piglets. Although the
antimicrobial composition of the ASL was similar in CF
and non-CF piglets, the airways from the CF pigs showed a
reduced efficiency in bacterial killing, and they suggested
that the acidic pH was the cause for the lack of activity of
antimicrobial molecules [34]. Moreover, in primary HBEs,
the decreased ASL pH also increased Na? and fluid
absorption, because the secreted protein short palate lung
and nasal epithelial clone 1 (SPLUNC1) effectively was
not able to inhibit ENaC-dependent Na? absorption and
preserve ASL volume, when ASL pH was acidic [36].
Finally, mucus properties are also regulated by pH, and
different groups have shown the negative impact of an
acidic pH on mucus rheology [65, 87–89]. In a review
published in 2008, Quinton hypothesized that the original
cause of the different organ pathologies in CF would be the
loss of HCO3
- , which would affect mucin expansion and
mucus gel formation. Indeed, before they are released,
mucins are in a very condensed form in granules. This
compact form is maintained within the granules by a high
concentration of cations, specifically Ca2? and H? [90, 91].
Upon release of mucins, HCO3
- would complex with Ca2?
and H?, allowing mucin chains to fully expand and form a
gel [65].
As stated above, CFTR regulates extracellular (luminal)
pH. It appears to do this by its ability to conduct HCO3
- as
well as Cl-. However, as discussed in more detail in the
section on the pancreas, CFTR may also be able to regulate
ASL pH via an indirect route through regulating the
activity of SLC26 Cl-/HCO3
- exchangers, such as pendrin
and potentially other members of the SLC26 family
(Fig. 3). The reciprocal regulatory interaction between the
SLC26 and CFTR involves binding of the STAS domain to
the regulatory domain of CFTR (see section on pancreas).
The SLC26 transporter SLC26A4, pendrin, has been shown
to be upregulated in inflammatory conditions in airway
epithelia such as chronic rhinosinusitis [92, 93], upon
stimulation with IL-17 [94] and in response to bacterial
infections [95]. The other mechanism that involves CFTR
in ASL pH regulation is its capacity to regulate Cl-/
HCO3
- anion exchange, and more particularly, SLC26A4
in airway epithelial cells. In serous cells, an increase in
cAMP triggered HCO3
- secretion through the apical mem-
brane. Using genetically modified cell lines (Calu-3 WT,
CFTR knockdown and pendrin knockdown), the authors
showed that this effect was CFTR-dependent but that
although fluid secretion was mainly mediated through
CFTR, the cAMP-induced rise in HCO3
- secretion was
mediated via pendrin [96].
Regulation of pulmonary innate immunity
ASL pH is also a crucial factor for an efficient immune
response to eradicate trapped pathogens and prevent their
propagation. Indeed, it has been shown that the activity of
molecules such as the protease inhibitor SPLUNC1, which
regulates antimicrobial peptides (AMPs) and shows itself
antimicrobial activity [97], depends on optimal ASL pH
[36, 98], as does the activity of AMPs themselves [34]. On
a more general level, when pathogens enter the airways,
they are recognised by epithelial cells that activate
inflammatory pathways to recruit immune cells, specifi-
cally neutrophils, into the airway lumen to eradicate the
infection. It has been shown that CFTR regulates this
process and when CFTR is absent, there is an upregulation
of proinflammatory molecules. The current debate is
whether the exacerbated inflammation in CF is due to the
sustained infection or to the defective CFTR channel. In
2007, Verhaeghe et al. showed the overexpression of
proinflammatory proteins in the airways of 24 weeks old
CF foetuses [99]. Moreover, Tirouvanziam showed in 2000
and 2002 that a graft of non-infected tracheas or distal
airways from CF foetuses on severe combined immunod-
eficiency (SCID) mice induced an increase in IL-8 and the
recruitment of neutrophils [100, 101]. However, since the
development of the CF pig model, it has been shown that
inflammatory markers in bronchoalveolar lavages (BALs)
of the lung did not differ from non-CF piglets, although the
CF pigs showed a marked increased susceptibility to
infection [102]. However, a recent transcriptomic study
showed that although levels of inflammatory markers did
not change, CF pig airways responded with a diminished
host defence response after infection with S. aureus, when
compared to non-CF pigs [103].
In addition, CFTR transports glutathione (GSH) [104]
and thiocyanate (SCN-) [105], and both molecules have
been shown to have a crucial role in the regulation of the
immune response in the lungs. GSH is a sulfhydryl con-
taining tripeptide that can bind and inactivate oxidants.
Reactive oxygen species (ROS) can be produced endoge-
nously (from inflammatory cells) or come from exogenous
sources (pollution, cigarette smoke). Their endogenous
production is important for the antimicrobial defence of the
lungs, but a sustained increase in ROS can lead to
increased inflammation and tissue damage. It is, therefore,
important for the epithelium to be able to inactivate ROS
once the infection has been eradicated. As a GSH trans-
porter, it has been shown that a defective CFTR leads to a
reduced concentration of GSH in the ASL [106] which will
impair the redox balance in the airways. SCN- is an anion
that plays an important role in the antimicrobial defence of
the lungs by reducing tissue-damaging species such as
hydrogen peroxide (H2O2) and hypochlorite (OCl
-) by
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subjecting itself to oxidation by lactoperoxidase, producing
hypothiocyanite (OSCN-). OSCN- itself has been shown
to have antimicrobial activity [107] and SCN- protected a
lung cell line from injury caused by H2O2 and from OCl
-
[108]. The absence of CFTR in CF and other inflammatory
lung pathologies leads to an abnormal antioxidant com-
position of the ASL, worsening airway inflammation and
damaging the epithelium. Epithelial tissue damage triggers
signalling cascades that lead to wound repair to prevent
potential pathogens to enter the bloodstream. In a process
called epithelial restitution, the injured epithelial cells go
through different de-differentiation and re-differentiation
stages to proliferate, fill the ‘‘gap’’, and recover their full
functionality [109]. It has been shown that CFTR plays a
critical role in this mechanism. Although it is not clear
whether a defective CFTR decreases or enhances wound
healing, many studies show that bronchial epithelial cells
lacking CFTR are not able to reconstitute a fully differ-
entiated epithelium [110–112].
In conclusion, CFTR has a fundamental role in the
physiology of the airways. It is involved directly and
indirectly in anion secretion that is crucial for airways
hydration, ASL pH and defence homeostasis (Fig. 3).
Potential therapies for CF have proven difficult to imple-
ment, possibly because CFTR is engaged in so many
different functions in the airways. However, as correctors
and potentiators of CFTR are being developed, another
possible way to compensate for defective CFTR would be
to target alternative ion channels or transporters such as the
SLC26 family members (A4 or A9), or the anoctamins,
short-circuiting their regulation by CFTR and rebalancing
ASL homeostasis. One important advantage of this ‘alter-
nate non-CFTR approach’ is that it would benefit all CF
patients regardless of genotype, and would potentially be
useful for other pathologies in which CFTR has been
shown to be downregulated such as COPD.
Role of CFTR in the exocrine pancreas
The pancreas is composed of both exocrine and endocrine
glands. The exocrine pancreas secretes *2 L/day of an
isotonic, HCO3
- rich fluid, containing a complex mixture
of digestive enzymes (zymogens), classically known as
pancreatic juice. The exocrine pancreas is composed
mainly of two types of epithelial cells; acinar cells which
make up *90 % by volume of the gland, and ductal cells
which make up the remaining 10 %, with a small propor-
tion of mucus secreting and endocrine cells. The ductal
cells form a complex, tubular, network which ramifies
throughout the gland [113] (Fig. 4). CFTR is highly
expressed in the apical membrane of ductal cells but is not
present in acinar cells [114, 115], and is essential for
electrolyte and fluid secretion from the gland. The impor-
tance of this fluid secretion to pancreatic function is well
demonstrated in CF, where the lack of CFTR-dependent
fluid secretion leads to near complete destruction of the
gland at birth in *85 % of people with CF [116, 117].
In terms of functional roles, the acinar cells secrete a
small volume of an NaCl-rich secretion plus many types of
digestive enzymes (8–20 g per day) in an inactive form,
together with various factors (e.g., ATP) that contribute to
cell signalling within the ductal system [118]. Acinar cells
secrete in response to stimulation by acetylcholine, chole-
cystokinin (CCK), and several other agonists. These
agonists cause a rise in intracellular calcium which stim-
ulates NaCl and fluid secretion, as well the regulated
exocytosis of enzyme-containing secretory granules [119].
Recent studies have also shown that following regulated
exocytosis the local pH falls to approximately 6.8, due to
proton secretion that accompanies exocytosis [120]
(Fig. 5a).
The ductal cells forming the intercalated, and/or
intralobular and interlobular ducts express CFTR (varies
with species) and are responsible for secreting an isotonic,
highly alkaline, fluid containing up to 160 mM NaHCO3
-.
However, the composition of the secretion is very much
flow dependent in all species studied [113, 118, 121]. There
is a reciprocal relationship between HCO3
- and Cl- con-
centrations: as fluid secretory rate increases, so does
HCO3
- concentration with a corresponding reduction in
Cl- concentration. At maximal flow rates, HCO3
- con-
centration peaks around 140–160 mM in most species
except the rat and mouse, where the maximum is around
70 mM [113, 118]. The major physiological regulator of
pancreatic HCO3
- secretion is the peptide hormone,
secretin, which is released from intestinal cells mainly in
response to acid chime entering the intestine. Binding of
secretin to ductal cells stimulates a rise in intracellular
cAMP and activation of PKA, which leads to an increase in
CFTR activity through phosphorylation of the channel, as
described in detail in the chapter ‘‘Biochemistry and
Physiology of CFTR’’. Other transporters required for
HCO3
- secretion are also regulated by cAMP/PKA (see
below).
While the role of the enzymes in digestion is clear, the
functions of pancreatic electrolyte secretion are less pre-
cise, but include acting as a vehicle for transporting the
inactive digestive enzymes to the small intestine where the
HCO3
- helps to neutralise gastric acid and so elevate duo-
denal pH to the optimal value required by the digestive
enzymes. Since HCO3
- is a chaotropic anion, it will also
aid disaggregation of secreted enzymes following exocy-
tosis, as well as help in mucin secretion and gel formation
as described in the section on the airways. In addition,
HCO3
- acts to neutralise the protons that are cosecreted
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with enzymes from the acinar cells. Maintaining a neutral
to alkaline luminal pH is important for the membrane
dynamics of acinar cells and, consequently, the exocytosis
of zymogen granules [122]. Furthermore, lower extracel-
lular pH has been shown to enhance secretagogue-induced
zymogen activation within acinar cells [123]. Finally,
recent studies have provided strong evidence that adequate
HCO3
- secretion is essential for preventing premature
autoactivation of trypsin by protons within the ductal tree,
and therefore inhibiting autodigestion of the gland. Indeed,
Fig. 4 Simplified structure of
the pancreas. The exocrine
pancreas is composed of acini
that surround a central lumen
open to the duct system. Acinar
cells (AC) secrete digestive
enzymes into small intercalated
ducts (ICD) where the
pancreatic duct cells (PDC)
raise the pH of the pancreatic
juice (PJ). These ducts are
directly connected to
increasingly larger intralobular
(intraLD) and interlobular
(interLD) ducts that join the
main pancreatic duct
Fig. 5 Ion transport in acinar (a) and pancreatic duct cells (b).
a Upon stimulation with acetylcholine, cholecystokinin or other
agonists, intracellular [Ca2?] increases and stimulates NaCl and fluid
secretion, as well as the exocytosis of enzyme-containing secretory
granules. As these granules also contain H?, the local pH falls to
approximately 6.8. Cl- secretion occurs through a CaCC on the apical
membrane. b CFTR conducts Cl- and HCO3
- and works in concert
with a Cl-/HCO3
- apical exchanger, to mediate net transepithelial
HCO3
- secretion, with Cl- recycling across the apical membrane.
Na? moves paracellularly in response to transepithelial HCO3
-
secretion, and water follows osmotically, to produce a HCO3
--rich
isotonic fluid. Cl- accumulates across the basolateral membrane via
NKCC1 and accumulation of HCO3
- inside the cells occurs through
the hydration of CO2 to HCO3
- and H? by carbonic anhydrase (CA),
together with backward transport of H? via the basolateral Na?/H
exchanger (NHE). This is driven by the Na? gradient established by
the Na?/K?-ATPase. The Na?-Bicarbonate cotransporter (NBC)
helps accumulate HCO3
- within the cell and maintain an electrical
driving force for efflux of HCO3
- across the apical membrane. It also
works with K? channels to maintain a negative membrane potential
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trypsin itself has been shown to reduce CFTR-dependent
HCO3
- secretion from duct cells [124], through activation
of apical proteinase-activated receptor-2, which leads to
further trypsin autoactivation. Furthermore, a fall in ductal
HCO3
- secretion appears particularly important in pro-
tecting the pancreas from developing acute pancreatitis
induced by stresses such as bile and alcohol [125], the two
most common causes of pancreatitis in man (see below).
Role of CFTR in pancreatic HCO3
2 secretion
As described in the section on the airways, CFTR is
known to conduct a variety of anions, including Cl- and
HCO3
-. Early patch clamp studies from rat and human
pancreatic duct cells demonstrated that under near physi-
ological gradients, CFTR was approximately 5 times more
permeable to Cl- than to HCO3
- [126–129]. This finding,
together with microelectrode studies from intact ducts that
demonstrated the presence of a SITS-sensitive Cl-/HCO3
-
exchange activity on the apical membrane together with
an NPPB-sensitive Cl- conductance [130, 131], combined
with intracellular pH measurements [132], led to the first
model of HCO3
- secretion that is shown in Fig. 5b
[126, 130, 131]. In this model, CFTR was seen to act
purely as Cl- secretory channel that worked in concert
with an apical Cl-/HCO3
- exchanger, to mediate net
transepithelial HCO3
- secretion from the duct cells, with
Cl- recycling across the apical membrane. Na? then
moves paracellularly in response to transepithelial HCO3
-
secretion, and water follows osmotically, to produce a
HCO3
- -rich isotonic fluid. In essence, CFTR’s role is to
help maintain the activity of the exchanger by providing a
source of luminal Cl-, as well as limiting intracellular Cl-
accumulation, through the operation of the exchanger,
which would ultimately put a break on HCO3
- efflux by
the exchanger. In this early model, Cl- was shown to be
accumulated across the basolateral membrane via NKCC1,
and active accumulation of HCO3
- inside the duct cells
was achieved through the hydration of CO2 to HCO3
- and
H? by carbonic anhydrase, together with backward
transport of H?, via the basolateral NHE. The latter step
being driven by the inwardly directed Na? gradient
established by the basolateral Na?/K?-ATPase. In contrast
to the rat, the pig was shown to express a basolateral H?-
ATPase that served a similar purpose to the NHE [133].
While this CFTR/anion-exchanger model for HCO3
-
secretion satisfied the early electrophysiological results
from the rat gland (which only secretes about 70 mM
NaHCO3), it was soon apparent that this model had seri-
ous deficiencies and could not explain the secretion of
near isotonic (140–160 mM) NaHCO3 juice secreted by
the human pancreas, as well as many other species, such
as the cat, pig, and guinea-pig [113, 118]. Indeed,
computer modelling of pancreatic HCO3
- secretion
clearly showed that this arrangement of transporters would
only be capable of achieving HCO3
- levels of *80 mM
[134, 135]. Partial resolution to this apparent problem
came when the molecular identity of the putative Cl-/
HCO3
- exchanger was identified and found to be due to
expression of several members of the SLC26 family of
anion transporters, SLC26A3 and SLC26A6 [136–138],
which were introduced in the section on the airways. Both
these exchangers are electrogenic with A3 transporting
2Cl- for 1HCO3
- (therefore causing net Cl- accumulation
per transport cycle), while A6 transported 2HCO3
- out of
the cell for one Cl- into the cell [139]. Therefore, the
direction and magnitude of anion transport is not only
dependent on the prevailing chemical gradients for Cl-
and HCO3
- across the apical membrane, but is also
affected by membrane potential. However, it is generally
believed that SLC26A6 mediates the majority of the Cl-/
HCO3
- exchange at the apical membrane based on inhi-
bitor profile (DIDS-sensitivity) and studies from
transgenic slc26a6 knock-out mice [140]. Furthermore,
pioneering studies from the Muallem lab showed that both
SLC26A exchangers were regulated by CFTR [141–144]
through a physical interaction between the phosphorylated
R domain of CFTR and the highly conserved STAS
domain of the SLC26 transporter. This physical coupling
between CFTR and the exchanger not only functionally
activated anion exchange activity, but also had a positive
effect on CFTR, and led to an increase in Po [136, 143],
although the mechanism for both these effects is currently
not understood. In addition, the physical coupling of these
two anion transporters was shown to be facilitated by their
binding to several scaffold proteins such as NHERF1 and
CAP50, via their respective C-terminal PDZ binding
motifs, which brings CFTR and SLC26A exchangers in
close proximity, essentially forming a multimeric, anion
transporting, complex [136, 141, 145]. In relation to
HCO3
- secretion, and particularly in the case of
SLC26A6, computer modelling showed that having a 2:1
electrogenic Cl-/HCO3
- transporter on the apical mem-
brane, working with CFTR, could theoretically increase
HCO3
- to *120 mM [135]. Although this value was
significantly higher than could be achieved by a 1:1 Cl-/
HCO3
- exchanger, it was still less than the measured
values in human pancreatic juice (140 mM). The reason
for this was that the capacity of the exchanger to increase
HCO3
- was found to be limited once luminal HCO3
-
levels increased above 120 mM, since it would be oper-
ating close to equilibrium (i.e., very slowly), during the
secretion of 140 mM HCO3
-. Taken together with the
observation that guinea-pig ducts can still secrete HCO3
-
into a luminal fluid nominally free of Cl- [146], this
suggested that neither of the SLC26 transporters provided
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the main route for HCO3
- efflux across the apical mem-
brane during maximal secretion. The final answer to the
puzzle came from several observations. First, it was found
that stimulation of HCO3
- secretion by cAMP agonists in
intact guinea-pig ducts led to a very marked drop in
intracellular Cl- [147], and this reduction in intracellular
[Cl-] was subsequently shown to activate a kinase cascade
involving the WNK1-OSR1/SPAK pathway, that ulti-
mately led to phosphorylation of CFTR (or a regulatory
protein) and a marked increase in the relative permeability
of CFTR to HCO3
- [148]. In addition, the low Cl- con-
centration in the lumen also caused CFTR to shift its
selectivity in favour of HCO3
- ions [149]. All of these
factors, therefore, ensure that a HCO3
--rich secretion is
produced with much of the secreted HCO3
- entering the
lumen via CFTR.
This increase in the relative HCO3
- conductance of
CFTR, together with the observed membrane potential
of *60 mV of stimulated duct cells [146, 150], was
found to be capable of further increasing ductal HCO3
-
levels to *140–160 mM. However, when comparing
ductal secretion from different species, it was also
apparent that those species that produced a relatively low
HCO3
--containing secretion (rat, mouse, and rabbit),
had significant levels of NKCC1 activity, while high
HCO3
- secretors did not, and instead expressed mainly
the Na?-dependent HCO3
- transporter, NBCe1
(SLC4A4) [151], an electrogenic HCO3
- importer with a
2HCO3
- to 1Na? stoichiometry [113, 152]. In the latter
case, the NBC not only helped accumulate HCO3
-
within the cell, by utilising the inward-directed sodium
gradient across the basolateral membrane, but it also
importantly helped maintain an electrical driving force
for efflux of HCO3
- across the apical membrane, by
offsetting the depolarisation of the cell due to electro-
genic anion secretion [151, 153, 154]. The NBC,
therefore, works in concert with potassium channels that
are found in ductal cells, to maintain a negative mem-
brane potential [155]. Furthermore, like CFTR, NBC
activity is positively regulated by cAMP/PKA phospho-
rylation [156], and both proteins are synergistically
regulated in a coordinated fashion by intracellular
IRBIT, in a cAMP and calcium-dependent manner
[157, 158]. Together, these data suggest that the flow-
dependent changes in luminal Cl-/HCO3
- concentra-
tions observed both in vivo and in vitro studies
[113, 118] can be attributed to dynamic alterations in the
mechanism of anion secretion through regulatory chan-
ges in CFTR and SLC26A6 activities. However, because
HCO3
- secretion is controlled by the activity of CFTR,
the production of a high luminal HCO3
- fluid must
occur relatively high up in the ductal tree (intercalated/
intralobular ducts), where CFTR is expressed [114, 115].
It should also be noted that there are inhibitory pathways
that limit the extent of pancreatic HCO3
- and fluid secre-
tion, probably to prevent excessive hydrostatic pressure
building up within the ductal tree at high secretory flow
rates [113]. Several studies have shown that these inhibi-
tory pathways work through the release of
neurotransmitters such as Substance P, that lead to a
reduction in HCO3
- secretion by selectively reducing
apical Cl-/HCO3
- exchange activity through a PKC-de-
pendent pathway [159–161].
Defects in CFTR-dependent HCO3
2 secretion
predispose to pancreatic disease
Several studies have indicated that insufficient ductal
HCO3
- and fluid secretion leads to the destruction of the
gland, as observed in the inherited disease CF
[116, 162, 163]. An important consequence of impaired
HCO3
- secretion is an acidic pancreatic juice (less than
6.5) that increases mucus viscosity, and decreases the
solubility of secreted digestive enzymes. Both these factors
predispose to the formation of mucin/protein plugs and
eventually cysts within the ductal tree, as well as premature
activation of digestive enzymes. This ultimately leads to
the destruction of the gland which is one of the charac-
teristic pathological features of CF of the pancreas [65]. As
discussed in Chapter ‘‘Cystic Fibrosis: a clinical view’’,
mutations in the CFTR gene cause CF. There are over 2000
disease causing mutations which have been grouped into
5–6 classes based on the functional consequences of the
mutation. Classes 1–3 are severe mutations, while Classes
4–5 are mild mutations. In relation to pancreatic pathol-
ogy, *85 % of people with CF are born pancreatic
insufficient (PI), which equates to a reduction in pancreatic
function of more than 95 %. In these people, there is a very
good correlation between disease severity and the class of
mutation [164–166] with ‘severe’ CF mutations, such as
the most common CF mutation, F508del and the class 3
gating mutant, G511D, strongly correlating with PI. For
those with ‘milder’ mutations (some residual channel
activity such as Class 4, R117H), pancreatic function is
preserved (pancreatic sufficient, PS), albeit to differing
extents. However, in general, these PS individuals require
less enzyme supplements, but can become PI with age. As
described above, the increase in activity of the apical
SLC26A6 anion exchanger during secretion appears to be
strongly dependent on its interaction with CFTR, and
interestingly, the exchanger is activated by a number of
CFTR mutants that lack Cl- channel activity [167]. This
correlates with a good retention of pancreatic function in
patients carrying those mutations [168]. Furthermore, anion
transport studies from polarised cultures of the human CF
pancreatic ductal cell line CFPAC, which is homozygous
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for F508del, showed that in addition to a lack of CFTR,
apical SLC26A Cl-/HCO3
- exchange activity was also
absent, despite evidence for mRNA expression. Impor-
tantly, anion exchange activity was restored upon viral-
mediated CFTR transduction of the CFPAC cells [169].
Taken together, these results strongly suggest that a func-
tional CFTR at the apical plasma membrane is a
prerequisite for SLC26A-mediated anion exchange, and
that mild CFTR mutations are likely to preserve Cl-/
HCO3
- exchange activity, although this needs more formal
demonstration.
Several recent investigations have also shown that two
agents that classically induce stress/inflammation of the
exocrine pancreas (pancreatitis), bile and alcohol, caused
marked changes in HCO3
- and fluid secretion based on
in vitro intracellular pH and fluid transport studies from
isolated microdissected ducts. At low concentrations, both
agents increased HCO3
- secretion, a response that required
CFTR and Cl-/HCO3
- exchange activity [170–172].
However, higher levels of these agents led to a severe
inhibition of CFTR-dependent HCO3
- secretion, which
was due to profound mitochondrial damage and a conse-
quent reduction in intracellular ATP levels [173, 174].
These studies were the first to suggest that ductal HCO3
-
secretion could play a protective role against these noxious
agents not hitherto thought of. Further support for this
hypothesis came from studying the extent of pancreatic
inflammation and necrosis caused by these agents in vivo,
using either CFTR knock-out mice or a mouse model with
reduced CFTR expression (NHERF1 KO mouse) [182]. In
both cases, the extent of pancreatic pathology induced by
administration of these noxious agents was significantly
increased, highlighting a key role of CFTR in pancreatic
protection. Furthermore, patients with autoimmune [175]
or acute and chronic alcohol-induced pancreatitis, showed
marked abnormalities in membrane localisation and
expression levels of CFTR [176]. Finally, there is a sig-
nificant correlation between the development of
pancreatitis and variants in the CFTR gene that do not
cause a typical CF phenotype, but appear to have impaired
HCO3
- secretion [177–179].
In summary, CFTR plays an essential role in HCO3
-
and fluid secretion in the exocrine pancreas. It regulates
HCO3
- secretion in two fundamentally different ways;
first, as a regulator of SLC26A-mediated Cl-/HCO3
-
exchange, and second, as a direct exit pathway for HCO3
-
secretion. Defects in CFTR-mediated HCO3
- transport
lead to severe pancreatic dysfunction. Strategies for
improving HCO3
- secretion in the CF pancreas are limited
because of the marked tissue destruction at birth in the
majority of people with CF. However, preliminary results
from measurements of pancreatic function in young chil-
dren with CF taking the Class 3 CFTR potentiator,
Ivacaftor (see Chapter ‘‘Cystic Fibrosis: a clinical view’’)
over 24 weeks, have shown a significant restoration of
enzyme-secreting capacity (increased faecal elastase-1
levels), and by inference, pancreatic tissue regeneration,
which is an extremely exciting finding [180] that warrants
further research. Furthermore, it is known that variants
(SNPs) in the SLC26A9 anion transporter can influence
disease severity in the CF lungs and gut (meconium ileus)
and, therefore, act as gene modifiers. Importantly, a recent
study has suggested that SNPs in SLC26A9 can also
influence the degree of pancreatic insufficiency [181]. This
opens up the possibility of targeting this anion transporter
as a potential therapeutic target to slow the progression of
exocrine dysfunction in CF (in addition to the lungs and
ileum).
In terms of pancreatitis, recent animal studies have
suggested that strategies that help maintain levels of
HCO3
- secretion would limit the extent of pathology
induced by bile and alcohol [174, 176, 182]. Furthermore,
the effects of ethanol and ethanol metabolites on CFTR are
consistent with reduced biogenesis, accelerated plasma
membrane turnover, as well as channel inhibition [176].
Thus, restoring cell surface expression and activity of
CFTR may partly alleviate the ethanol-induced damage.
This potentially could be through the use of the FDA
approved drug, Lumacaftor (see Chapter ‘‘Cystic Fibrosis:
a clinical view’’), which improves folding and processing
of F508del-CFTR to the plasma membrane, as well as
Ivacaftor to improve channel activity. Another goal here
would be to find ways of preventing the marked reduction
in ATP levels in ductal (and acinar) cells [125, 183]. A
potential clinical strategy would be to try and improve
nutritional support at a very early stage in acute pancre-
atitis, although a recent trial looking at the benefits of
nasoenteric feeding after *20 h of admission did not show
any improvement in outcome compared to those patients
that had on-demand oral feeding commencing at 24 h
[184].
Role of CFTR in sweat gland physiology
The human eccrine (or atrichal) sweat gland helps to
maintain whole body temperature via the production of
sweat in response to a hot environment, exercise, or emo-
tional situations. An individual can secrete up to 4L of
sweat in an hour to thermoregulate [185, 186]. Sweat
consists primarily of water and salt, mostly NaCl but is
hypotonic with respect to the interstitium. The sweat gets
secreted onto the surface of the skin, where heat is lost
from the body by the latent heat of evaporation of the sweat
fluid. The ability to lose heat is affected by the prevailing
outside temperature as well as humidity. However, it is
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increasingly being recognised that sweat has a number of
other important roles which include the production and
secretion of a range of AMPs such as LL-37, lactoferrin
and dermicidin, an AMP unique to skin [187–189], as well
as compounds that maintain skin condition (barrier func-
tion) and skin lubricants [190]. Sweat glands also contain
stem cells important for renewing skin after wounding and
burns [186, 191]. A number of disorders of sweat glands
exist, with most involving defects in electrolyte and fluid
production. These include CF, where lack of functional
CFTR prevents normal NaCl absorption and leads to
excessive salt loss ([192]; reviewed by [193]) which is
discussed in more detail below; idiopathic anhidrosis (de-
creased volume of secretion), which may be caused by
defects in calcium signalling [194, 195] and hyperhidrosis
(uncontrolled and excessive sweat secretion), that may be
due to changes in calcium signalling and water transport by
aquaporin 5 [196, 197]). In addition, lack of sufficient
antimicrobials can lead to skin infections and atopic der-
matitis [198], and problems with wound healing and re-
epithelialisation may be linked to stem cell dysfunction
[191, 199, 200].
Eccrine sweat glands are derived from embryonic
ectoderm (as is the exocrine pancreas), and it is estimated
that there are 2–4 million glands dispersed over the sur-
face of the body, with the highest density on the forehead,
palms of the hands and soles of the feet. The human
sweat gland is a simple, coiled tubular, exocrine gland,
2–5 mm in length that resides in the lower part of the
dermis, and which connects to the surface of the skin by a
straight absorptive duct [186, 193]. The gland is com-
posed of two structurally and functionally different units
[201, 202] (Fig. 6). (1) The secretory coil (Fig. 6a) that
makes up most of the coiled part of the gland and which
is responsible for producing the primary secretion mainly
in response to sympathetic cholinergic innervation, but
beta-adrenergic stimulation also elicits a low volume
secretion. The secretory coil is composed of three cell
types. There is a single layer of epithelial cells, which
consist of two morphologically and functional distinct
types of cells known as clear (agranular) and dark
(granular) cells which occur in equal proportions
(Fig. 6a). These cells are responsible for producing the
primary ‘sweat’ secretion, together with various glyco-
proteins and AMPs, respectively [185, 203]. Clear cells
express CFTR [203, 204] as well as a CaCC, most
probably TMEM16A (ANO1) [205]. The myoepithelial
cells are the third type of cells (Fig. 6a), and are modified
smooth muscle cells that contract during sweat secretion,
and which provide structurally integrity to the secretory
coil preventing damage to the tubule during gland stim-
ulation [206]. (2) The absorptive straight duct (Fig. 6b)
that acts to absorb NaCl, but not water, producing the
final, hypotonic, sweat secretion that flows out to the skin.
The absorption of salt, but not water, helps minimise salt
loss from the body, which, if not controlled, could lead to
circulatory collapse. Structurally, the proximal part of the
absorptive duct is composed of a double layer of
epithelial cells, which are electrically connected by gap
junctions, and physically joined by desmosomes, to form
a syncytium [202]. Further up towards the skin exit, the
distal part of the duct consists of multiple layers of cells
and is not thought to be involved in electrolyte or fluid
transport [185].
Fig. 6 Schematic representation of an eccrine sweat gland. The
human sweat gland is a simple-coiled tubular exocrine gland that
resides in the dermis and connects to the surface of the skin by a
straight absorptive duct. a The secretory coil duct epithelium is
composed of clear (CC), dark (DC), and myoepithelial cells (MEC),
and is responsible for producing the primary secretion. b The
reabsorptive duct epithelium is composed of two layers of cuboidal
cells which absorb salt but not water
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Role of CFTR in sweat gland electrolyte and fluid
transport
CFTR is expressed in both portions of the sweat gland and
has been shown to be involved in the elaboration of the
primary secretion from the secretory coil in response to
beta-adrenergic stimulation, as well as in the absorption of
NaCl in the absorptive duct [193]. However, in the secre-
tory coil, the major physiological stimulus is acetylcholine
(ACh), which is released from post-ganglionic sympathetic
cholinergic fibres, and which stimulates copious fluid
transport through a non-CFTR dependent pathway.
Although not fully resolved, the most likely Cl- exit
pathway is via the TMEM16A Cl- channel, which has
been localised to secretory cells [205], and which is acti-
vated by increases in cytosolic calcium via cholinergic
stimulation. However, recent studies suggest that dark cells
may also contribute to sweat secretion, but employ a dis-
tinct anion channel known as best2 (see [186] for further
discussion), which may have an additional role in sweat pH
and fluid regulation. Furthermore, studies from isolated
sweat glands from adult mouse foot pads have shown
expression of the mRNA for the Chloride Intracellular
Channel 6 (Clic6), as well as for the slc26a4 Cl-/HCO3
-
anion exchanger known as pendrin. The latter protein could
play a role in HCO3
- secretion [207], as discussed in the
section on the airways. In the clear cells at least, the pro-
duction of the primary secretion involves accumulation of
Cl- above electrochemical equilibrium by a basolateral
NKCC1, followed by Cl- exit through apical-located Cl-
channels, CFTR or TMEM16A. This creates a lumen
negative potential difference that drives paracellular
transport of Na?, and water follows osmotically via
aquaporins to produce an isotonic secretion, contain-
ing *145 mM Na?, 115 mM Cl-, with the remaining
anions being lactate and HCO3
- [185].
The duct cells express the highest levels of CFTR, and
in contrast to all other CF-affected epithelial tissues, the
channel is functionally present at both apical and basolat-
eral membranes [193, 208], and appears to be
constitutively active [209] via PKA activity. Similar to the
airways, ENaC is also expressed with CFTR at the apical
membrane. However, there are marked differences in the
way the two tissues operate (Compare Figs. 3 and 7). In the
sweat duct, both Na? and Cl- move transcellularly and
both channels work together to regulate net transepithelial
NaCl absorption. Indeed, pioneering work from the Quin-
ton lab showed that ENaC activity was dependent on a
functional interaction with a phosphorylated, Cl- trans-
porting, CFTR [193, 210, 211], highlighting a completely
different regulatory interaction between the two channels.
Exactly how the activities of CFTR and ENaC are coor-
dinated is still not fully established but may be due to
changes in intracellular pH that accompany Na? absorption
through ENaC [212]. In the duct cells, (as in the airways)
Na? entry occurs through ENaC down a large electro-
chemical gradient. Intracellular Na? is then pumped out of
the cell across the basolateral membrane to the interstitial
fluid by the Na?/K?-ATPase, generating a transepithelial
electrical gradient favouring Cl- absorption (Fig. 7b).
Fig. 7 Ion transport in the sweat gland. a Secretory coil duct
epithelial cells secrete NaCl and water mainly in response to
cholinergic (acetylcholine, ACh) stimulation. b The reabsorptive
duct epithelial cells express a constitutively active CFTR on both
apical and basolateral membranes. Both Na? and Cl- move
transcellularly and both ENaC and CFTR work together to regulate
net transepithelial NaCl absorption. Na? is pumped out of the cell
across the basolateral membrane to the interstitial fluid by the Na?/
K?-pump, generating a transepithelial electrical gradient favouring
Cl- absorption
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However, unlike the airways, the paracellular pathway in
the absorptive duct has little intrinsic Cl- permeability in
both normal and CF glands [208, 213] and due to high
anion conductance of the apical and basolateral membranes
of the duct cells (due to active CFTR), Cl- moves tran-
scellularly. Indeed, the declining Na? concentration in the
sweat fluid creates a driving force for passive Cl- entry
into the cell through active CFTR, and then, Cl- exits via
basolateral CFTR [185, 193]. Through this process NaCl
concentration can fall to *50 mM, before diffusion of Cl-
becomes limited by luminal Cl- concentration [214], at
least under normal flow rates. However, it has been
observed that at low flow rates Cl- levels can fall as low as
10–15 mM, and pH becomes very acidic [215], which must
involve a different set of transporters. As discussed by
Bovell [185], this could be due to a yet unidentified apical
Cl-/HCO3
- exchanger that is coupled to proton-secretion
via a V-type ATPase [216, 217], leading to net Cl-
absorption. Because of the low water permeability of the
duct epithelium, NaCl absorption does not lead to con-
current water movement, and therefore, the resulting
modified fluid is hypotonic, thus conserving valuable salt
for whole body salt and fluid homeostasis [193].
Sweat gland and cystic fibrosis
As discussed above, CFTR has an important role in elec-
trolyte and fluid secretion as well as absorption. In people
with CF, dysfunctional CFTR affects both processes, and
this leads to two important clinical manifestations of the
disease. (1) Although rates of cholinergic sweat secretion
are very similar in non-CF and CF individuals, beta-
adrenergic (cAMP) secretion is absent in CF [218]. (2) The
inability of the sweat duct to absorb Cl- prevents Na?
transport, and therefore, salt absorption is markedly
reduced and sweat NaCl levels rise, producing an abnor-
mally ‘salty’ sweat, one of the hallmarks of the disease.
Although, under normal conditions, this is not a major
clinical problem, during hot and humid conditions, people
with CF can lose excessive salt and fluid, causing dehy-
dration and heat prostration as originally observed by
Dorothy Anderson [219]. Indeed, the increase in sweat
forms the basis of the Quantitative Pilocarpine Ion-
tophoresis Test (QPIT) that is still used today for
diagnostic purposes [220, 221]. This test measures the
concentration of Cl- in sweat and requires iontophoretic
introduction of pilocarpine (a cholinergic agonist) to
stimulate local sweating and then sufficient sweat is col-
lected for analysis of Cl-. Concentrations of Cl- in excess
of 60 mM in children are diagnostic of CF. Normal values
are less than *40 mM. More recently, four new assays
have been introduced to assess both the secretory and
reabsorptive capacity of sweat glands. These assays can
measure changes in bioelectric potentials, which are higher
in CF glands compared to normal [222], as well as skin
impedance and rates of secretion, thus improving overall
sensitivity and diagnostic value in sweat gland pathologies
(see [221]) for a recent summary of these new tests).
In summary, CFTR plays an important role in both salt
and fluid secretion and absorption in the sweat gland,
which is similar to the airways. However, in marked con-
trast to the airways, the ability of CFTR to regulate NaCl
absorption relies on a positive interaction and regulation of
ENaC; in other words, CFTR works with ENaC, and not
against it! Exactly how two channels in the same mem-
brane have completely different regulatory interactions is
intriguing but poorly understood, and requires further
research. Uniquely, CFTR is expressed in both apical and
basolateral membranes of duct epithelial cells, although the
underlying mechanism for this dual targeting has not been
elucidated. Undoubtedly, cell/tissue specific regulatory
interactions will have a role to play, but little is known in
the sweat gland of these processes. It is intriguing that
recent work form the CF pig has shown CFTR is not
expressed in the plasma membrane of smooth muscle cells
but is targeted to the sarcoplasmic reticulum [223], which
illustrates the importance of cell context in relation to
CFTR targeting. Defects in CFTR-mediated Cl- transport
lead to severe sweat gland dysfunction and excessive salt
loss in CF. Although not a major clinical problem, there is
no doubt that the sweat gland has been pivotal to our
general understanding of the role of CFTR in CF which has
been eloquently summarised in a recent review by Paul
Quinton [193], and it still holds great promise as a diag-
nostic tool for evaluation of new therapies for CF in this
age of personalised (N = 1) medicine [224].
Final summary
CFTR has a central role in coordinating electrolyte and fluid
transport in a range of epithelial tissues including the air-
ways, GI and reproductive tracts and secretory glands. It
achieves this not only by acting as a conduit for anion
transport (its ion channel function), but also through its
varied and complex regulation of other, non-CFTR chan-
nels, and anion transporters (its transporter regulatory
function), that also participate in salt and fluid transport.
Through this activity, CFTR has a key role in maintaining
epithelial integrity and defence of the body as a whole.
Although we have only described the role of CFTR in three
epithelial tissues, we chose these primarily to illustrate the
varied functional roles of CFTR. Understanding the basis for
these different activities of CFTR has not only helped us
gain a better understanding of the role of CFTR in the
physiology of the tissue, but importantly, has led to the
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development of new and better strategies to help overcome
CFTR-related pathologies. This is best exemplified by the
development of a new generation of small molecule thera-
pies being used to treat the basic defect in CF, which is
described in more detail in Chapter ‘‘Cystic Fibrosis: a
clinical view’’. However, this approach is also being applied
to CFTR-dependent secretory diarrhoeas, and may be rele-
vant to other disease in which a link to CFTR malfunction is
emerging, such as acute pancreatitis, COPD and asthma.
However, we still lack precise details about the underlying
molecular mechanisms that endow CFTR with the ability to
modulate other transporters and defence mechanisms, so
further research is clearly important and warranted.
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